Evolvere BioSciences
ActiveMaking Next-Generation Antibiotics that Outpace Bacterial Evolution
What it does
🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.
Next to it in Healthcare and bio · AI-powered antibiotic discovery
- Axiom TherapeuticsPlug and Play PnP 2025
AI-powered covalent drug discovery for untreatable cancers
- Harmonic DiscoveryY Combinator S21
Multi-targeted therapeutics to treat complex diseases
- Ångström AIY Combinator S24
Gen AI molecular simulations that reproduce wetlab results
- CytodymeTechstars TS 2025
Cytodyme
- ConvexiaY Combinator S25
The world's first AI-maximalist pharma company
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease